Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 79
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01192295 | Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids | ||
| NCT00531427 | Buprenorphine Transdermal System (BTDS) in Subjects w/Mod-sev Osteoarthritis (OA) Chronic Pain of Knee | ||
| NCT05808881 | Clinical Outcomes From Nalmefene | ||
| NCT01259115 | Buprenorphine Accumulation and Description of Its Metabolites During Co-Medication of Buprenorphine Transdermal System (BTDS) and Ketoconazole | ||
| NCT00315445 | The Safety and Efficacy of the Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Back Pain. | ||
| NCT00315458 | Buprenorphine Transdermal Patch in Subjects With Osteoarthritis Pain Requiring Opioids. Includes a 52-Week Safety Extension. | ||
| NCT03008447 | Crossover Study to Evaluate the Effect of Lemborexant Versus Placebo and Zolpidem on Postural Stability, Auditory Awakening Threshold, and Cognitive Performance in Healthy Subjects 55 Years and Older | ||
| NCT00315887 | The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Back Pain. | ||
| NCT00315874 | The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Low Back Pain. | ||
| NCT06285214 | Study of V117957 in Interstitial Cystitis/Bladder Pain Syndrome | ||
| NCT00490919 | Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Chronic Low Back Pain | ||
| NCT01427270 | Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain | ||
| NCT01358526 | Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain | ||
| NCT01125917 | Safety of BTDS in Subjects With Low Back Pain: A 52-Week Extension Phase of BUP3015 | ||
| NCT06719986 | Pharmacodynamic Evaluation of Intramuscular Nalmefene Autoinjector 1.5 mg Compared to Intranasal Narcan 4 mg | ||
| NCT02970500 | Effect of Methylphenidate on Cancer-related Cognitive Impairment | ||
| NCT01688947 | Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN) | ||
| NCT03001557 | Study of Lemborexant for Irregular Sleep-Wake Rhythm Disorder and Mild to Moderate Alzheimer's Disease Dementia | ||
| NCT02583451 | Study to Evaluate the Effect of Lemborexant Versus Placebo on Driving Performance in Healthy Adult and Elderly Subjects | ||
| NCT00315835 | Safety of the Buprenorphine Transdermal Delivery System in Subjects With Mod-to-Sev Pain Following Orthopedic Surgery. | ||
| NCT03299556 | Effect of Wearable Health Technology on Patients Treated for Chronic Pain at Geisinger Health System | ||
| NCT01160614 | Pharmacokinetics and Safety of ORF Tablets in Pediatric Patients | ||
| NCT02225639 | PRC-063 in an ADULT Workplace Environment | ||
| NCT02139111 | PRC-063 in Adolescent ADHD | ||
| NCT00312195 | Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Nonmalignant Pain | ||
| NCT00313846 | Safety and Efficacy of Buprenorphine Transdermal System in Subjects With Moderate to Severe Osteoarthritis of Hip or Knee | ||
| NCT06024642 | Study of V117957 in Overactive Bladder Syndrome | ||
| NCT04507204 | Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) | ||
| NCT03483636 | Study of Lemborexant-Alcohol Interaction in Healthy Subjects | ||
| NCT03471871 | Study to Evaluate the Respiratory Safety of Lemborexant in Adult and Elderly Healthy Subjects and Adult and Elderly Subjects With Mild Obstructive Sleep Apnea | ||
| NCT01151098 | Safety of Buprenorphine Transdermal Systems in Subjects With Chronic Nonmalignant Pain - a 28-week Extension Study | ||
| NCT01101308 | A Study to Determine the Fasting Bioequivalence of Reformulated OXY Tablets Manufactured at Two Different Facilities | ||
| NCT02796625 | Alpha as a Predictive Biomarker | ||
| NCT02243241 | The Effect of Hydrocodone Bitartrate (HYD) Extended-Release Tablets on QT /QTc Intervals in Healthy Adult Subjects | ||
| NCT01688934 | Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis (OA) of the Knee | ||
| NCT01900795 | An Analgesic Study to of V117957 for the Treatment of Postsurgical Pain Due to Third Molar Extraction | ||
| NCT01324544 | Pharmacokinetics, Safety, and Efficacy of Intravenous Dosing of Buprenorphine in Pediatric Patients Who Require Opioid Analgesia for Acute Moderate to Severe Pain | ||
| NCT03440424 | Study to Evaluate the Pharmacokinetics of Lemborexant (E2006) and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared to Healthy Subjects | ||
| NCT01259102 | Examine Plasma Concentrations of Buprenorphine Following Reapplication of Buprenorphine Transdermal System (BTDS) After Variable Application Site Rest Periods | ||
| NCT01400139 | Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period. | ||
| NCT01099709 | A Study to Determine the Fed Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets | ||
| NCT01101178 | To Determine the Fed Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets | ||
| NCT04172415 | Current Procedural Sedation Practices in a Canadian Community Emergency Department | ||
| NCT00320801 | Buprenorphine Transdermal Patches (BTDS) in Subjects With Osteoarthritis Pain. Includes a 52-week Extension Phase. | ||
| NCT04035200 | Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation | ||
| NCT02695745 | Experimental Biomarker Study for Pain Thresholds | ||
| NCT01324570 | Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children | ||
| NCT01100320 | A Study to Determine the Fed Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets | ||
| NCT00313833 | Safety and Effectiveness of Buprenorphine Transdermal System in Elderly Subjects With Chronic Pain: Pilot Study. | ||
| NCT01148537 | The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) on QT Intervals in Healthy Volunteers |
